MedPath

Evaluation the effects of Bupivacaine and dexmedetomidine on postoperative functional and pai

Phase 2
Conditions
pain.
Generalized pain NOS
R52.9
Registration Number
IRCT20160430027677N16
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

aged 20 to 70 years
American Society of Anesthesiologists physical status classification I and II
Absence of extensive damage to the rotator cuff

Exclusion Criteria

History of allergy to used drugs
The history of drug addiction
Known coagulation disorders
History of renal disease
History of liver disease
Body mass index more than 35 kg/m2

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.;Function. Timepoint: On the day before surgery and on postoperative day. Method of measurement: QoR-40 scoring system.
Secondary Outcome Measures
NameTimeMethod
Mean Arterial Blood Pressure. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Electrocardiogram.;Sleep disturbance. Timepoint: Until 24 hours after surgery. Method of measurement: Ten point scale.
© Copyright 2025. All Rights Reserved by MedPath